2013 onwards

Selected List

  1. P. Saini, R. Ganugula, M. Arora, M. N. V. Ravi Kumar. The next generation non-competitive active polyester nanosystems for transferrin receptor-mediated peroral transport utilizing gambogic acid as a ligand. Sci. Rep. 6, 29501 (doi: 10.1038/srep29501) 2016.
  2. P. Saini, M. Arora, M. N. V. Ravi Kumar. Poly(lactic acid) blends in biomedical applications Adv. Drug Del. Rev. (In Press)
  3. M. Guada, A. Beloqui, M.N.V. Ravi Kumar, V. Préat, C. Dios-Viéitez Mdel, M. J. Blanco-Prieto. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy. J. Control. Release 225: 269-282, 2016.
  4. V. P. Venkatpurwar, S. Rhodes S, K.A. Oein, M.A. Elliott, H.G. Jørgensen, C.D. Tekwe, M. N. V. Ravi Kumar. Drug- not carrier-dependent haematological and biochemical changes in a repeated dose study of cyclosporine encapsulated PLGA nano- and micro-particles: size doesn’t matter. Toxicology. 330: 9-18, 2015.
  5. D. A. Lamprou, V. Venkatpurwar and M. N. V. Ravi Kumar. Atomic force microscopy images label-free, drug encapsulated nanoparticles in vivo and detects difference in tissue mechanical properties of treated and untreated: A tip for nanotoxicology. PLoS One. 8, e64490, 2013.
  6. C. N. Grama, P. Suryanarayana, M. A. Patil, G. Raghu, M. N. V. Ravi Kumar and G. Bhanuprakash Reddy. Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. PLoS One  8, e78217, 2013.
  7. C.N. Grama, V.P. Venkatpurwar, D.A. Lamprou, M. N. V. Ravi Kumar. Towards scale-up and regulatory shelf-stability testing of curcumin encapsulated polyester nanoparticles. Drug Deliv. Transl. Res.  3, 286-293, 2013.